1. Home
  2. HLIT vs IOVA Comparison

HLIT vs IOVA Comparison

Compare HLIT & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HLIT
  • IOVA
  • Stock Information
  • Founded
  • HLIT 1988
  • IOVA 2007
  • Country
  • HLIT United States
  • IOVA United States
  • Employees
  • HLIT N/A
  • IOVA N/A
  • Industry
  • HLIT Radio And Television Broadcasting And Communications Equipment
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HLIT Technology
  • IOVA Health Care
  • Exchange
  • HLIT Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • HLIT 1.2B
  • IOVA 975.1M
  • IPO Year
  • HLIT 1995
  • IOVA N/A
  • Fundamental
  • Price
  • HLIT $9.64
  • IOVA $2.46
  • Analyst Decision
  • HLIT Buy
  • IOVA Buy
  • Analyst Count
  • HLIT 5
  • IOVA 12
  • Target Price
  • HLIT $13.13
  • IOVA $10.36
  • AVG Volume (30 Days)
  • HLIT 1.1M
  • IOVA 20.0M
  • Earning Date
  • HLIT 11-03-2025
  • IOVA 11-06-2025
  • Dividend Yield
  • HLIT N/A
  • IOVA N/A
  • EPS Growth
  • HLIT N/A
  • IOVA N/A
  • EPS
  • HLIT 0.43
  • IOVA N/A
  • Revenue
  • HLIT $635,710,000.00
  • IOVA $250,425,000.00
  • Revenue This Year
  • HLIT N/A
  • IOVA $65.15
  • Revenue Next Year
  • HLIT $25.21
  • IOVA $58.47
  • P/E Ratio
  • HLIT $22.44
  • IOVA N/A
  • Revenue Growth
  • HLIT 1.93
  • IOVA 175.62
  • 52 Week Low
  • HLIT $7.80
  • IOVA $1.64
  • 52 Week High
  • HLIT $13.75
  • IOVA $9.63
  • Technical
  • Relative Strength Index (RSI)
  • HLIT 47.62
  • IOVA 55.93
  • Support Level
  • HLIT $8.74
  • IOVA $2.09
  • Resistance Level
  • HLIT $9.42
  • IOVA $2.55
  • Average True Range (ATR)
  • HLIT 0.34
  • IOVA 0.22
  • MACD
  • HLIT -0.04
  • IOVA 0.01
  • Stochastic Oscillator
  • HLIT 55.62
  • IOVA 56.82

About HLIT Harmonic Inc.

Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: